Company intelligence / Profile preview

KOKA Lifesciences

Nantong / Shanghai, Jiangsu Sheng / Shanghai municipality, Chinakokalife.com ↗

Ownership: Private
Development stage: Phase 1

Overview

KOKA Lifesciences is conducting ongoing clinical trials for its transcatheter aortic valve implantation system, targeting patients with severe aortic stenosis. The company also develops devices for transcatheter mitral valve repair. No published results from pivotal or late-stage studies are available as of the latest updates.

Therapeutic areas: Cardiovascular
Modalities: Device (Transcatheter heart valve systems)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on KOKA Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KOKA Lifesciences.

Explore the full profile